Mayflower Financial Advisors LLC Sells 1,781 Shares of CVS Health Co. (NYSE:CVS)

Mayflower Financial Advisors LLC trimmed its holdings in CVS Health Co. (NYSE:CVS) by 15.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,482 shares of the pharmacy operator’s stock after selling 1,781 shares during the quarter. Mayflower Financial Advisors LLC’s holdings in CVS Health were worth $426,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of the business. MidAtlantic Capital Management Inc. bought a new stake in shares of CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter worth $31,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health in the third quarter worth $31,000. Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter worth about $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new position in CVS Health in the 3rd quarter worth about $33,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

Several research analysts have issued reports on CVS shares. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Barclays lowered their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $68.12.

CVS Health Stock Performance

NYSE:CVS opened at $57.00 on Thursday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a 50-day simple moving average of $51.27 and a two-hundred day simple moving average of $56.18. The firm has a market capitalization of $71.73 billion, a PE ratio of 14.47, a P/E/G ratio of 0.80 and a beta of 0.59. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same period in the previous year, the company posted $2.21 EPS. The firm’s revenue was up 6.3% on a year-over-year basis. Analysts forecast that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.67%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.